A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis

A randomised, parallel-group clinical trial comparing bedinvetmab to meloxicam for the management of canine osteoarthritis

Bedinvetmab (Librela®), a fully canine anti-nerve growth factor monoclonal antibody, was compared to the non-steroidal anti-inflammatory drug (NSAID) meloxicam in dogs for the management of osteoarthritis-related pain in a randomised, open-label, multicentre, parallel-group study. Subjects were recr...

Full description

Saved in:
Bibliographic Details
Main Authors: John F. Innes, B. Duncan X. Lascelles, Daniel Bell, Robert Tulloch, Alex McVey, Chad Northcott, Mahala Welbourn, Kate Higgins, Veronika Horakova, Thomas W. Maddox
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-03-01
Series:Frontiers in Veterinary Science
Subjects:
bedinvetmab
meloxicam
canine orthopaedic index
canine osteoarthritis
degenerative joint disease
monoclonal antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2025.1502218/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fvets.2025.1502218/full

Similar Items